AMAG AMAG Pharmaceuticals Inc.

11.4
0  0%
Previous Close 11.4
Open 11.51
Price To Book 0.77
Market Cap 386,467,763
Shares 33,900,681
Volume 1,220,550
Short Ratio
Av. Daily Volume 1,397,286

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2/3 top-line data due 1H 2020.
AMAG-423 / Digoxin immune fab (DIF)
Severe preeclampsia in pregnant women
FDA approval announced June 21, 2019.
Vyleesi (Bremelanotide)
Female sexual dysfunction (FSD)
Approval for sNDA filing announced February 5, 2018.
Feraheme
Adults with iron deficiency anemia (IDA)
Approval announced February 14, 2018.
Makena - auto injector
Reduce the risk of preterm birth in women with a singleton pregnancy
Phase 3b trial did not meet co-primary endpoints. Advisory Committee planned for 4Q 2019. Data to be published 2H 2019.
Makena
Preterm birth
Phase 3a trial to be initiated 4Q 2019.
Ciraparantag
Anticoagulated reversal agent / Healthy volunteers

Latest News

  1. Palatin's (PTN) to Report Q4 Earnings: What's in the Cards?
  2. Gene therapies to test FDA's approach to regulating drugs after launch, experts say
  3. [video]New York Investment Firm Discloses 10.3% Amag Stake, May Propose Changes
  4. Have Insiders Been Buying AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Shares?
  5. Edited Transcript of AMAG earnings conference call or presentation 7-Aug-19 12:00pm GMT
  6. Jim Cramer Shares His Thoughts On Delta Air Lines, Okta And More
  7. AMAG PHARMACEUTICALS ANNOUNCES GRANT OF INDUCEMENT AWARDS UNDER NASDAQ LISTING RULE 5635(c)(4)
  8. Why AMAG Pharmaceuticals Stock Jumped Today
  9. AMAG Pharmaceuticals Inc (AMAG) Q2 2019 Earnings Call Transcript
  10. AMAG Q2 Loss Widens, Sales Lag Estimates, 2019 Guidance Cut
  11. What's Behind AMAG Pharmaceuticals' Horrible Q2 Results
  12. AMAG Pharmaceuticals (AMAG) Reports Q2 Loss, Misses Revenue Estimates
  13. AMAG Pharmaceuticals Announces Second Quarter 2019 Financial Results and Provides Corporate Update
  14. UPDATE 1-Amag's female libido injectable therapy to sell at $899
  15. Amag's female libido injectable therapy to sell at $899
  16. AMAG Pharmaceuticals (AMAG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
  17. AMAG Pharmaceuticals to Host Second Quarter 2019 Financial Results Conference Call and Webcast on Wednesday, August 7, 2019 at 8:00 a.m. ET
  18. Will AMAG Pharmaceuticals (AMAG) Report Negative Q2 Earnings? What You Should Know
  19. AMAG (AMAG) to Report Q2 Earnings: What's in the Cards?
  20. Calculating The Intrinsic Value Of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG)